Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population

Journal of Medical Virology

Volumn 71, Issue 2, 2003, Pages 298-304

  Chala, Silvia R ^a   García Barreno, Blanca ^a   Melero, José A ^a   Palomo, Concepción ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Binding; Human RSV; Neutralizing antibodies

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; NORMAL HUMAN; PREVALENCE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PREVALENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SPAIN;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0042355637     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10483     Document Type: Article

References (29)

1. Anderson LJ, Heirholzer JC, Tson C, Hendry RM, Fernie BN, Stone Y, McIntosh K. 1985. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 151: 626-633.
2. Bembridge GP, García-Beato R, López JA, Melero JA, Taylor G. 1998. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/ c mice sensitized to the attachment G protein. J Immunol 161:2473-2480.
3. Bembridge GP, López JA, Bustos R, Melero JA, Cook R, Mason H, Taylor G. 1999. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J Virol 73:10086-10094.
4. Blasco R, Moss B. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157.
5. Collins PL, Chanock RM, Murphy BR. 2001. Respiratory syncytial virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott/Williams & Wilkins. p 1443-1485.
6. Connors M, Collins PL, Firestone CY, Murphy BR. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 65:1634-1637.
7. Falsey AR, Walsh EE. 1998. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis 177:463-466.
8. Falsey AR, Walsh EE. 2000. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 13:371-384.
9. Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, Irvine CS, Kolassa JE, Barker WH, Treanor JJ. 1995. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 43:30-36.
10. Falsey AR, Walsh EE, Looney RJ, Kolassa JE, Formica MA, Criddle MC, Hall WJ. 1999. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults. J Med Virol 59:221-226.
11. Finger R, Anderson LJ, Dicker RC, Harrison B, Doan R, Downing A, Corey L. 1987. Epidemic infections caused by respiratory syncytial virus in institutionalized young adults. J Infect Dis 155:1335-1339.
12. García O, Martín M, Dopazo J, Arbiza J, Frabasile S, Russi J, Hortal M, Pérez-Breña P, Martínez I, Garcí a-Barreno B, Melero JA. 1994. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol 68:5448-5459.
13. Glezen WP, Taber LH, Frank A, Kasel J. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140:543-546.
14. Hall WJ, Hall CB, Speers DM. 1978. Respiratory syncytial virus infection in adults: clinical, virologic and serial pulmonary function studies. Ann Intern Med 88:203-205.
15. Hall CB, Walsh CB, Long CE, Schnabel KC. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163:693-698.
16. Johnson PR, Spriggs MK, Olmsted RA, Collins PL. 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci USA 84:5625-5629.
17. Lamprecht CL, Krause HE, Mufson MA. 1976. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 134:211-217.
18. Martínez I, Melero JA. 1998. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein. J Gen Virol 79:2215-2220.
19. Martínez I, Dopazo J, Melero JA. 1997. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78:2419-2429.
20. Melero JA, García-Barreno B, Martínez I, Pringle CR, Cane PA. 1997. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 78:2411-2418.
21. Mufson MA, Örvell C, Rafnar B, Norrby E. 1985. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66:2111-2124.
22. Palomo C, Cane PA, Melero JA. 2000. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J Med Virol 60:468-474.
23. Perez M, García-Barreno B, Melero JA, Carrasco L, Guinea R. 1997. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology 235:342-351.
24. Roberts SR, Lichtenstein D, Ball LA, Wertz GW. 1994. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol 68:4538-4546.
25. Taylor G, Stott EJ, Bew M, Fernie BF, Collins AP, Hughes M, Jebbett J. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
26. Walsh EE, Hall CB, Briselli M, Brandiss MW, Schlesinger JJ. 1987. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis 155: 1198-1204.
27. Watt PJ, Robinson BS, Pringle CR, Tyrrell DAJ. 1990. Determinants of susceptibility to challenge and the antibody response of adults volunteers given experimental respiratory syncytial virus vaccines. Vaccine 8:231-236.
28. Wilson SD, Roberts K, Hammond K, Ayres JG, Cane PA. 2000. Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies. J Med Virol 61:81-84.
29. Woelk CH, Holmes EC. 2001. Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol 52:182-192.